Draft Guidance on Medical Device Recalls: Improvements Are Needed

On February 22, 2013, FDA issued a draft guidance intended to help medical device manufacturers distinguish product enhancements from recalls. Unfortunately, the draft guidance created more questions than it answered. This article discusses, among other things, a new interpretation of the Part 806 reporting requirements that would substantially increase the regulatory burden for device manufacturers.